ATE127517T1 - Verfahren und produkte zur feststellung von menschlichem t-zellen-leukämie-virus. - Google Patents

Verfahren und produkte zur feststellung von menschlichem t-zellen-leukämie-virus.

Info

Publication number
ATE127517T1
ATE127517T1 AT84901861T AT84901861T ATE127517T1 AT E127517 T1 ATE127517 T1 AT E127517T1 AT 84901861 T AT84901861 T AT 84901861T AT 84901861 T AT84901861 T AT 84901861T AT E127517 T1 ATE127517 T1 AT E127517T1
Authority
AT
Austria
Prior art keywords
leukemia virus
cell leukemia
products
methods
glycoprotein
Prior art date
Application number
AT84901861T
Other languages
English (en)
Inventor
Myron E Essex
Tun-Hou Lee
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23942758&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE127517(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of ATE127517T1 publication Critical patent/ATE127517T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT84901861T 1983-04-27 1984-04-13 Verfahren und produkte zur feststellung von menschlichem t-zellen-leukämie-virus. ATE127517T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48918783A 1983-04-27 1983-04-27

Publications (1)

Publication Number Publication Date
ATE127517T1 true ATE127517T1 (de) 1995-09-15

Family

ID=23942758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84901861T ATE127517T1 (de) 1983-04-27 1984-04-13 Verfahren und produkte zur feststellung von menschlichem t-zellen-leukämie-virus.

Country Status (7)

Country Link
EP (1) EP0151579B1 (de)
JP (1) JP2780020B2 (de)
AT (1) ATE127517T1 (de)
AU (1) AU583473B2 (de)
DE (1) DE3486404T2 (de)
FI (1) FI89175C (de)
WO (1) WO1984004327A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
JPS6044870A (ja) * 1983-08-22 1985-03-11 Fujirebio Inc 成人ｔ細胞白血病ウイルス抗体検出用試薬
US7232654B1 (en) 1983-09-15 2007-06-19 Institut Pasteur DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1)
US7205102B1 (en) 1983-09-15 2007-04-17 Institut Pasteur Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA
GB8423659D0 (en) 1984-09-19 1984-10-24 Pasteur Institut Cloned dna sequences
GB8429099D0 (en) 1984-11-16 1984-12-27 Pasteur Institut Closed dna sequences
JPS6061534A (ja) * 1983-09-16 1985-04-09 Kyowa Hakko Kogyo Co Ltd 成人ｔ細胞白血病ウイルス抗原ペプチド
US4731237A (en) * 1983-11-07 1988-03-15 The Wistar Institute Immune response to virus induced by anti-idiotype antibodies
US5053224A (en) * 1983-11-07 1991-10-01 Hilary Koprowski Induction of antibody response to solid tumors with anti-idiotype antibodies
US7351412B1 (en) 1983-12-05 2008-04-01 Institut Pasteur Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA
US5610035A (en) * 1983-12-05 1997-03-11 Institut Pasteur Centre National De La Recherche Scientific Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies
US4724258A (en) * 1984-02-03 1988-02-09 Juridical Foundation, Japanese Foundation For Cancer Research Adult T cell leukemia virus antigen polypeptide
EP0152030A3 (de) * 1984-02-03 1986-08-13 Juridical Foundation Japanese Foundation for Cancer Research Adult-T-Zell-Leukemiavirus-Antigenpolypeptid
US5705612A (en) 1984-10-18 1998-01-06 Institut Pasteur And Centre National De La Recherche Scientifique NEF peptide encoded by human immunodefiency virus type 1 (HIV-1)
US7045130B1 (en) 1984-10-18 2006-05-16 Institut Pasteur Antibodies against antigens of human immunodeficiency virus (HIV-1)
EP0201540B2 (de) * 1984-10-18 2001-10-31 Institut Pasteur Lymphadenopathie-assoziierte hüllenantigene und deren verwendungen
US6894152B1 (en) 1984-11-16 2005-05-17 Institut Pasteur Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA
JPS62501263A (ja) * 1984-11-29 1987-05-21 スクリツプス　クリニツク　アンド　リサ−チ　フアウンデ−シヨン 脱グリコシル化ウイルス糖タンパク質に関連するポリペプチド類および抗体
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
US5773210A (en) * 1985-04-19 1998-06-30 The United States Of America As Represented By The Department Of Health And Human Services Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
FR2590674B1 (fr) * 1985-11-25 1989-03-03 Inst Nat Sante Rech Med Nouveaux reactifs de diagnostic
WO1987003206A1 (en) 1985-11-25 1987-06-04 Quash Gerard A Modified viral glycoproteins, diagnostic and therapeutic uses therefore
US5364933A (en) 1986-03-03 1994-11-15 Institut Pasteur Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US6514691B1 (en) 1986-01-22 2003-02-04 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
FR2595826B1 (fr) * 1986-03-13 1990-09-07 Lurhuma Zirimwabagabo Produit d'immuno-essai, son procede de preparation, son utilisation, complexe immunogene le comportant et utilisation de ce complexe
DK155886D0 (da) * 1986-04-04 1986-04-04 Bo Arne Hofmann Vaccine og fremgangsmaade til fremstilling af denne
ATE86308T1 (de) * 1986-08-04 1993-03-15 Us Commerce Menschlicher b-lymphotroper virus (hblv), isolierung und erzeugnisse.
DE3788424T2 (de) * 1986-08-11 1994-04-28 Us Commerce Testverfahren des menschlichen b-lymphotropen virus (hblv).
EP0321489B1 (de) * 1986-08-12 1993-03-17 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Molekulare klonierung und human b lymphotropischer virus klon (hblv)
ATE137801T1 (de) * 1988-07-06 1996-05-15 Verigen Inc A Corp Of Delaware Gegen hiv 1 gp48 spezifische antikörper
US5286852A (en) * 1988-07-06 1994-02-15 Verigen, Inc. Antibodies specific towards HIV-1 gp 48

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141783B2 (de) * 1983-11-07 1993-06-16 The Wistar Institute Durch antiidiotype Antikörper induzierte immune Antwort zu Tumoren und Viren
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay

Also Published As

Publication number Publication date
EP0151579A4 (de) 1988-09-28
DE3486404D1 (de) 1995-10-12
FI89175C (fi) 1993-08-25
FI89175B (fi) 1993-05-14
FI845061A0 (fi) 1984-12-20
AU583473B2 (en) 1989-05-04
DE3486404T2 (de) 1996-02-01
WO1984004327A1 (en) 1984-11-08
FI845061L (fi) 1984-12-20
EP0151579B1 (de) 1995-09-06
EP0151579A1 (de) 1985-08-21
JPS60501179A (ja) 1985-07-25
JP2780020B2 (ja) 1998-07-23
AU2826184A (en) 1984-11-19

Similar Documents

Publication Publication Date Title
ATE127517T1 (de) Verfahren und produkte zur feststellung von menschlichem t-zellen-leukämie-virus.
DE3587969D1 (de) Testverfahren zum nachweis von menschlichem lymphotropischem virus.
ATE140540T1 (de) Verfahren zur zurichtung eines verbesserten western-blott-immuntestverfahrens
DK602285D0 (da) Fremgangsmaade til paavisning af htlv-iii-virus og dettes derivater og antistoffer i serum fra aids-patienter samt testsystem til brug ved fremgangsmaaden
DE69022578D1 (de) Test für Hepatitis-C.
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
ES2139571T3 (es) Ensayo de hepatitis c que utiliza antigenos recombinantes.
EP0476130A4 (en) Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
KR950008537A (ko) 엡스타인 바 비루스(ebv)에 대한 항체의 검출용 진단제
SE8900721D0 (sv) Methods for detection of antibodies to
ES2145746T3 (es) Analisis de deteccion de hepatitis c.
ES2133269T3 (es) Gen receptor del factor de crecimiento derivado de plaquetas de tipo oc.
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
GR1000033B (el) Δοκιμασια για την ανιχνευση αντιγονων ηπατιτιδας και αντισωματων aids.
ATE132268T1 (de) Immuntest zum gleichzeitigen nachweis von hiv-1, hiv-2, htlv-i und htlv-ii antikörpern
WO1987007647A1 (en) Method for detection of antibodies to htlv-iii virus and diagnostic test kit useful therewith
ATE143142T1 (de) Immunoassay zum nachweis von antikörpern gegen hiv
DK0491713T3 (da) Rubella El-peptider og C-peptider
ATE270345T1 (de) Nukleinsaeure erkennung von hepatitis gb virus
DK619984A (da) Fremgangsmaade og produkter til detektering af humant t-celleleukaemivirus
NO165128C (no) Fremgangsmaate for eliminering av falske positive resultater fra systemiske lupuserythematodes-pasienter ved bestemmelse av et atl-virusantistoff i en testproeve.
ES2163411T3 (es) Metodo para la identificacion de individuos infectados con vih y supervision de su terapia.
DE3854665D1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.
Settele Comparative evaluation of four commercially available ELISA test kits for the detection of FeLV in whole blood, plasma and saliva.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time